Azilsartan compared to ACE inhibitors in anti-hypertensive therapy: one-year outcomes of the observational EARLY registry
Crossref DOI link: https://doi.org/10.1186/s12872-016-0222-6
Published Online: 2016-03-08
Published Print: 2016-12
Update policy: https://doi.org/10.1007/springer_crossmark_policy
Gitt, Anselm K.
,
Bramlage, Peter
Potthoff, Sebastian A.
Baumgart, Peter
Mahfoud, Felix
Buhck, Hartmut
Ehmen, Martina
Ouarrak, Taoufik
Senges, Jochen
Schmieder, Roland E.
Funding for this research was provided by:
Takeda Pharmaceuticals North America (US)